A Phase I study of the safety and pharmacokinetics of the combination of pertuzumab (rhuMab 2C4) and capecitabine in patients with advanced solid tumours

J Albanell; C Montagut; ET Jones; L Pronk; B Mellado; J Beech; P Gascon; G Zugmaier; M Brewster; MP Saunders; JW Valle

A Phase I study of the safety and pharmacokinetics of the combination of pertuzumab (rhuMab 2C4) and capecitabine in patients with advanced solid tumours

J Albanell, C Montagut, ET Jones, L Pronk, B Mellado, J Beech, P Gascon, G Zugmaier, M Brewster, MP Saunders, JW Valle

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	2726-2731
Number of pages	5
Journal	Clinical Cancer Research
Volume	14
Issue number	9
Publication status	Published - May 2008

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{176808cd6d5a4df8afda316a05519bbe,

title = "A Phase I study of the safety and pharmacokinetics of the combination of pertuzumab (rhuMab 2C4) and capecitabine in patients with advanced solid tumours",

author = "J Albanell and C Montagut and ET Jones and L Pronk and B Mellado and J Beech and P Gascon and G Zugmaier and M Brewster and MP Saunders and JW Valle",

year = "2008",

month = may,

language = "English",

volume = "14",

pages = "2726--2731",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research",

number = "9",

}

TY - JOUR

T1 - A Phase I study of the safety and pharmacokinetics of the combination of pertuzumab (rhuMab 2C4) and capecitabine in patients with advanced solid tumours

AU - Albanell, J

AU - Montagut, C

AU - Jones, ET

AU - Pronk, L

AU - Mellado, B

AU - Beech, J

AU - Gascon, P

AU - Zugmaier, G

AU - Brewster, M

AU - Saunders, MP

AU - Valle, JW

PY - 2008/5

Y1 - 2008/5

M3 - Article

SN - 1078-0432

VL - 14

SP - 2726

EP - 2731

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 9

ER -